Scholars Central

Conference abstractPublished 19 Oct 2016

Using IPRs in the biosimilars context

Authors: Laura Burson

Sheppard, Mullin, Richter & Hampton LLP, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In Amgen v. Sandoz, the Federal Circuit held that biosimilar applicants are not required to provide their Biologics License Application (BLA) or engage in the patent dance âÂ?Â? the process under the BPCIA in which the parties identify which patents the parties believe should be litigated. However, the court held that an applicant who fails to provide its BLA must provide the brand with 180-daysâÂ?Â? notice of launch. In Amgen v. Apotex, the Federal Circuit held that a biosimilar applicant must always provide the brand with 180-daysâÂ?Â? notice before launch, regardless of whether the applicant provided its BLA or engaged in the patent dance. The result of these decisions may be that few biosimilars applicants engage in the patent dance. Rather than litigating biologics patents under the BPCIA, biosimilars applicants may challenge biologics patents by filing IPRs. We will review IPRs that have been filed in the biologics area, analyze key institution decisions, and provide takeaways from the institution decisions and our views on lessons that should be learned from these decisions.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • BylineArticles whose byline prints “Laura Burson”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels